Dr. Rogers is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
555 S 18th St
Ste 4C
Columbus, OH 43205Phone+1 614-224-6222Fax+1 614-241-5232
Education & Training
Indiana University School of MedicineResidency, Ophthalmology, 2003 - 2006- Indiana University School of Medicine/Methodist HospitalInternship, Transitional Year, 2002 - 2003
Wright State University Boonshoft School of MedicineClass of 2002
Certifications & Licensure
OH State Medical License 2007 - 2026
IN State Medical License 2003 - 2007- American Board of Ophthalmology Ophthalmology
Clinical Trials
- Bevacizumab Treatment For Type 1 ROP Start of enrollment: 2022 May 18
Roles: Contact
Publications & Presentations
PubMed
- Persistent Elevation of Opening Pressure Despite Treatment and Symptom Resolution in Pediatric Intracranial Hypertension.Lisa Pabst, Brandon S Aylward, David L Rogers, Shawn C Aylward
Pediatric Neurology. 2024-04-01 - Peripheral retinal finding on fluorescein angiography in neuronal ceroid lipofuscinosis type 2 (CLN2).David L Rogers, Emily De Los Reyes, Thomas A Mendel, Brian Caprul, Sarah Podlasiak
Journal of AAPOS. 2024-04-01 - 5 citationsOcular and developmental outcomes of a dosing study of bevacizumab for retinopathy of prematurity.David K Wallace, Amra Hercinovic, Sharon F Freedman, Eric R Crouch, Amit R Bhatt
Journal of AAPOS. 2023-02-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
